EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 28-Jun-2025 20:10 ET (29-Jun-2025 00:10 GMT/UTC)

New PET tracer identifies diverse invasive mold infections behind life-threatening illnesses in cancer and transplant patients

Society of Nuclear Medicine and Molecular Imaging
Peer-Reviewed Publication

A novel PET radiotracer can accurately detect a wide range of mold species that are linked to dangerous infections, according to new research presented at the Society of Nuclear Medicine and Molecular Imaging 2025 Annual Meeting. The imaging agent has the potential to dramatically enhance the diagnosis and monitoring of invasive mold infections in patients.

Journal: Journal of Nuclear Medicine
Meeting: Society of Nuclear Medicine and Molecular Imaging 2025 Annual Meeting

ImmunoPET tracer enhances early detection of liver cancer

Society of Nuclear Medicine and Molecular Imaging
Peer-Reviewed Publication

A novel molecular imaging agent targeting glypican-3 (GPC3) has demonstrated high sensitivity and specificity in detecting hepatocellular carcinoma (HCC), including tumors smaller than one centimeter, according to results from a pilot clinical study. The agent, ⁶⁸Ga-aGPC3-scFv, coded as XH06, was shown to be safe, well-tolerated, and effective at providing high-contrast images of GPC3-positive liver tumors, offering a promising new tool for early diagnosis and staging of HCC—one of the most lethal forms of liver cancer. This research was presented at the Society of Nuclear Medicine and Molecular Imaging 2025 Annual Meeting.

Journal: Journal of Nuclear Medicine

International Conference on Nutrition in Medicine tackles trending health topics from ultra-processed foods to Ozempic in Washington, DC, Aug. 14-16

Physicians Committee for Responsible Medicine
Meeting Announcement

Are some ultra-processed foods good for you? Could diet change be better than Wegovy or Ozempic for weight loss? What role does nutrition play in breast and prostate cancers, menopause, and Alzheimer’s disease? These are just a few of the trending nutrition topics that more than 25 of the world’s leading nutrition experts will examine at the 13th annual International Conference on Nutrition in Medicine from Aug. 14 to 16 in Washington, D.C.

Food insecurity linked to elevated mortality risk among cancer survivors

University of Pennsylvania School of Medicine
Peer-Reviewed Publication

Lack of access to healthy food is a threat to the lives of cancer survivors—a significant and often overlooked factor affecting their long-term health outcomes. A new study shows that those experiencing food insecurity had a 28 percent relative increase in risk of death as compared to those who were food secure.

Journal: JAMA Health Forum

Researchers discover new genetic target that could shape the future of liver cancer treatment

Virginia Commonwealth University
Peer-Reviewed Publication

Devanand Sarkar and a team of scientists at VCU Massey Comprehensive Cancer Center found that TAF2 is overexpressed in hepatocellular carcinoma patients compared to individuals with healthy livers. Through preclinical research, they discovered that TAF2 regulates the survival of hepatocytes—the functional cells of the liver—and tumor formation. Their study—recently published in the journal Hepatology—also demonstrates that TAF2 cooperates with the MYC gene, another known major driver of cancer, to accelerate tumor growth.

Journal: Hepatology
Funder: NIH/National Cancer Institute

Basic fibroblast growth factor-loaded hydrogel biomaterial patches for promoting the healing of esophageal anastomosis: An experimental animal study

National Center for Respiratory Medicine
Peer-Reviewed Publication

The application of hyaluronic acid methacrylate (HAMA) hydrogel biomaterial patches loaded with basic fibroblast growth factor (bFGF) in esophageal surgery improved the mechanical strength of the esophageal anastomosis, facilitated fibroblast proliferation and collagen secretion, and promoted the growth of the tissues around the esophageal anastomosis.

Journal: Journal of Thoracic Disease

SNMMI image of the year: New immuno-pet tracer superior to FDG PET in predicting PD-L1 expression in head and neck cancer

Society of Nuclear Medicine and Molecular Imaging
Peer-Reviewed Publication

A first-in-class peptide-based PET tracer, ¹⁸F-AlF-NOTA-PCP2, can effectively measure PD-L1 expression in patients with head and neck cancers, outperforming the conventional tracer ¹⁸F-FDG. ¹⁸F-AlF-NOTA-PCP2 uptake strongly correlated with PD-L1 levels,highlighting the tracer’s potential to improve patient stratification and guide personalized treatment strategies. This research was presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2025 Annual Meeting, and the grouping of images comparing ¹⁸F-AlF-NOTA-PCP2 and ¹⁸F-FDG uptake has been selected as the 2025 SNMMI Henry N. Wagner, Jr., Image of the Year.

Journal: Journal of Nuclear Medicine
Meeting: Society of Nuclear Medicine and Molecular Imaging 2025 Annual Meeting

BU medical students receive prestigious ASCO award

Boston University School of Medicine
Grant and Award Announcement

Second-year Boston University Chobanian & Avedisian School of Medicine students Teresia Perkins and Mathew Krick, have been chosen to participant in the 2025 Conquer Cancer Medical Student Rotation (MSR) from the American Society of Clinical Oncology (ASCO). MSR provides financial support for U.S. medical students who are interested in oncology as a career to experience a minimum four-week clinical or clinical research rotation.

Mizzou researchers part of team developing imaging tool that could transform brain cancer surgery

University of Missouri-Columbia
Peer-Reviewed Publication

In a significant leap forward for successful cancer surgery, researchers at the University of Missouri and collaborators have developed a new imaging probe to help surgeons more accurately identify and remove aggressive tumors during operations.

Journal: npj Imaging

Multi-institutional team awarded NCI grant to open novel AML trial

University of Cincinnati
Grant and Award Announcement

The University of Cincinnati Cancer Center (UC), The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) and Jabez Biosciences are partnering to open a new phase 1 clinical trial studying JBZ-001, a potential new treatment for acute myeloid leukemia (AML).

Funder: NIH/National Cancer Institute

6
7
8
9
10